Suchergebnisse - "Schlichting, Douglas"

PubPharm (55)

1

Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients

enthalten in: ResearchSquare.com | 2022

von Stebbing, J. | Krishnan, V. | de Bono, S. | +14

2

Pain Reduction in Rheumatoid Arthritis Patients Who Use Opioids : A Post Hoc Analysis of Phase 3 Trials of Baricitinib

enthalten in: ACR open rheumatology | 2022

von Pope, J. | Lee, Y. | Curtis, J. | +7

3

Radiographic Progression of Structural Joint Damage Over 5 Years of Baricitinib Treatment in Patients With Rheumatoid Arthritis : Results From RA-BEYOND

enthalten in: The Journal of rheumatology | 2022

von van der Heijde, D. | Kartman, C. | Xie, L. | +6

4

Pain Reduction in Rheumatoid Arthritis Patients Who Use Opioids : A Post Hoc Analysis of Phase 3 Trials of Baricitinib

enthalten in: ACR Open Rheumatology | 2022

von Pope, J. | Lee, Y. | Curtis, J. | +7

5

Clinical effectiveness and safety of baricitinib for the treatment of juvenile idiopathic arthritis-associated uveitis or chronic anterior antinuclear antibody-positive uveitis : study protocol for an open-label, adalimumab active-controlled phase 3 clinical trial (JUVE-BRIGHT)

enthalten in: Trials | 2021

von Ramanan, A. | Guly, C. | Keller, S. | +4

6

Clinical effectiveness and safety of baricitinib for the treatment of juvenile idiopathic arthritis-associated uveitis or chronic anterior antinuclear antibody-positive uveitis: study protocol for an open-label, adalimumab active-controlled phase 3 clinical trial (JUVE-BRIGHT)

enthalten in: Trials | 2021

von Ramanan, A. | Guly, C. | Keller, S. | +4

7

Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients

enthalten in: EMBO molecular medicine | 2020

von Stebbing, J. | Krishnan, V. | de Bono, S. | +20

CommentIn: EMBO Mol Med. 2020 Aug 7;12(8):e12817. - PMID 32569446

8

Efficacy and Safety of Long-Term Baricitinib With and Without Methotrexate for the Treatment of Rheumatoid Arthritis : Experience With Baricitinib Monotherapy Continuation or After Switching From Methotrexate Monotherapy or Baricitinib Plus Methotrexate

enthalten in: Arthritis care & research | 2020

von Fleischmann, R. | Takeuchi, T. | Schiff, M. | +8

9

Correction to : Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis

enthalten in: Arthritis research & therapy | 2020

von Emery, P. | Tanaka, Y. | Cardillo, T. | +5

ErratumFor: Arthritis Res Ther. 2020 May 15;22(1):115. - PMID 32414425

10

Correction to: Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis

enthalten in: Arthritis Research & Therapy | 2020

von Emery, P. | Tanaka, Y. | Cardillo, T. | +5

1
2
3
4
5
6
Nächster »
[6]